Free Trial

HC Wainwright's Rating of Elemental Royalty on 3/16/2026

On March 16, 2026, HC Wainwright updated its outlook on Elemental Royalty (NASDAQ:ELE) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from HC Wainwright

DateCompanyAction
5/12/2026
Can-Fite BioPharma Ltd. stock logo
CANF
Can-Fite BioPharma
Set Price Target
5/12/2026
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
Lower Price Target
5/12/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
Boost Price Target
5/12/2026
Climb Bio, Inc. stock logo
CLYM
Climb Bio
Boost Price Target
5/12/2026
Senseonics Holdings, Inc. Common Stock stock logo
SENS
Senseonics Holdings, Inc. Common Stock
Lower Price Target
5/12/2026
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
Lower Price Target
More Ratings From HC Wainwright